Scarica l'app Stockscreener
1.46
5.81%
-0.09
Dopo l'orario di chiusura:
1.46
Precedente Chiudi:
$1.55
Aprire:
$1.55
Volume 24 ore:
219.01K
Relative Volume:
1.32
Capitalizzazione di mercato:
$45.55M
Reddito:
$81,000
Utile/perdita netta:
$-41.04M
Rapporto P/E:
-1.1087
EPS:
-1.3169
Flusso di cassa netto:
$-30.69M
1 W Prestazione:
-2.67%
1M Prestazione:
-12.05%
6M Prestazione:
+16.80%
1 anno Prestazione:
-13.10%
Intervallo 1D:
$1.45
$1.5698
Intervallo di 1 settimana:
$1.45
$1.61
Portata 52W:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Nome
Actinium Pharmaceuticals Inc
Settore
Industria
Telefono
646-767-3870
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Confronta ATNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.46 | 48.67M | 81,000 | -41.04M | -30.69M | -1.3169 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Iniziato | B. Riley Securities | Buy |
| 2020-11-05 | Iniziato | Alliance Global Partners | Buy |
| 2017-12-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Ripresa | ROTH Capital | Buy |
| 2017-09-14 | Iniziato | Maxim Group | Buy |
| 2016-08-25 | Iniziato | ROTH Capital | Buy |
| 2016-02-29 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2014-10-01 | Iniziato | MLV & Co | Buy |
| 2014-07-22 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie
Is Actinium Pharmaceuticals Inc. still worth holding after the dipWeekly Investment Recap & Weekly High Conviction Ideas - newser.com
What high frequency data says about Actinium Pharmaceuticals Inc.2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals - TipRanks
Can Actinium Pharmaceuticals Inc. recover in the next quarterJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Actinium Pharmaceuticals (ATNM) Reveals Promising Data for NSCLC Treatment - GuruFocus
Actinium Shares Rise After Preclinical Data for ATNM-400 Show Potent Anti-Tumor Activity in Lung Cancer Models - MarketScreener
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire
Actinium to Present ATNM-400 Preclinical Data Highlighting Durable Tumor Control and Ability to Overcome Resistance to Standard-of-Care Prostate Cancer Therapies at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - Eastern Progress
Is Actinium Pharmaceuticals Inc. (Delaware) stock a contrarian opportunityMarket Risk Report & AI Powered Market Trend Analysis - newser.com
Why Actinium Pharmaceuticals Inc. (7AY1) stock remains stableWeekly Trading Summary & Verified Momentum Watchlists - newser.com
Will Actinium Pharmaceuticals Inc. (Delaware) stock beat international competitionInflation Watch & AI Forecasted Stock Moves - newser.com
How geopolitical risks impact Actinium Pharmaceuticals Inc. (7AY1) stockSell Signal & High Return Stock Watch Alerts - newser.com
Exit strategy if you’re trapped in Actinium Pharmaceuticals Inc.Market Weekly Review & High Conviction Buy Zone Picks - newser.com
Will Actinium Pharmaceuticals Inc. stock remain a Wall Street favoritePrice Action & Real-Time Volume Trigger Notifications - newser.com
Will Actinium Pharmaceuticals Inc. stock recover faster than marketJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Short interest data insights for Actinium Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com
Does Actinium Pharmaceuticals Inc. show high probability of rebound2025 Historical Comparison & Risk Managed Trade Strategies - newser.com
How big funds are accumulating Actinium Pharmaceuticals Inc. (7AY1) stockQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
How Actinium Pharmaceuticals Inc. (7AY1) stock performs in volatility spikesRate Cut & Real-Time Volume Analysis - newser.com
Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Actinium Pharmaceuticals Inc. stock trend forecast2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com
How to use Fibonacci retracement on Actinium Pharmaceuticals Inc.2025 Retail Activity & Safe Capital Growth Tips - newser.com
Published on: 2025-10-01 07:40:56 - newser.com
Is Actinium Pharmaceuticals Inc a good long term investmentTechnical Analysis Insights & Trusted Financial Advisors at No Cost - earlytimes.in
Actinium Pharmaceuticals, Inc. $ATNM Shares Sold by Goldman Sachs Group Inc. - Defense World
What drives Actinium Pharmaceuticals Inc 7AY1 stock priceVolume Analysis Techniques & Small Capital Wealth Plans - earlytimes.in
Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):